We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+8.25%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$51.1B
AUM Growth
+$5.52B
(+12%)
Cap. Flow
+$2.51B
Cap. Flow
% of AUM
4.91%
Top 10 Holdings %
Top 10 Hldgs %
25.02%
Holding
4,443
New
2,726
Increased
876
Reduced
774
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.21B |
| 2 |
Synopsys
SNPS
|
+$191M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$104M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$63.2M |
| 5 |
Mercado Libre
MELI
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$52.3M |
| 2 |
RGEF
Rockefeller Global Equity ETF
RGEF
|
+$43M |
| 3 |
RMOP
Rockefeller Opportunistic Municipal Bond ETF
RMOP
|
+$41.2M |
| 4 |
Zoetis
ZTS
|
+$38.2M |
| 5 |
Shell
SHEL
|
+$36.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Financials | 9.27% |
| 3 | Industrials | 6.08% |
| 4 | Consumer Discretionary | 5.91% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Jazz Pharmaceuticals
JAZZ
$16.7B
| $36.5M | 0.07% |
276,872
-4,010
| -1% | -$481K |
|
252
CME Group
CME
$94.8B
| $36.4M | 0.07% |
134,690
+23,754
| +21% | +$6.46M |
|
253
Vertex Pharmaceuticals
VRTX
$126B
| $36.3M | 0.07% |
92,814
-6,924
| -7% | -$2.89M |
|
254
JPMorgan Municipal ETF
JMUB
$8.47B
| $36.3M | 0.07% |
720,159
-637
| -0.1% | -$31.6K |
|
255
iShares MSCI KLD 400 Social ETF
DSI
$5.55B
| $36.2M | 0.07% |
287,057
+62,798
| +28% | +$7.59M |
|
256
Deere & Co
DE
$168B
| $35.9M | 0.07% |
78,476
+13,750
| +21% | +$6.78M |
|
257
Vanguard Russell 1000 Growth ETF
VONG
$45B
| $35.8M | 0.07% |
297,426
+13,850
| +5% | +$1.59M |
|
258
Corning
GLW
$143B
| $35.4M | 0.07% |
431,943
+17,272
| +4% | +$1.13M |
|
259
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
| $35.4M | 0.07% |
686,774
+63,536
| +10% | +$3.29M |
|
260
ONE Gas
OGS
$5.04B
| $35.3M | 0.07% |
436,645
+13,948
| +3% | +$1.04M |
|
261
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
| $34.6M | 0.07% |
681,508
+51,351
| +8% | +$2.6M |
|
262
Sherwin-Williams
SHW
$89.8B
| $34.5M | 0.07% |
99,741
+6,571
| +7% | +$2.32M |
|
263
Newmont
NEM
$119B
| $34.5M | 0.07% |
409,613
+2,962
| +0.7% | +$207K |
|
264
MetLife
MET
$62.4B
| $34.5M | 0.07% |
419,073
+15,082
| +4% | +$1.19M |
|
265
State Street SPDR S&P Dividend ETF
SDY
$23.9B
| $34.4M | 0.07% |
245,596
+14,551
| +6% | +$2.03M |
|
266
Idexx Laboratories
IDXX
$46.2B
| $34.3M | 0.07% |
53,753
-1,072
| -2% | -$651K |
|
267
Bristol-Myers Squibb
BMY
$132B
| $34.3M | 0.07% |
761,283
+38,569
| +5% | +$1.8M |
|
268
First Trust North American Energy Infrastructure Fund
EMLP
$4.08B
| $34.1M | 0.07% |
890,855
+22,154
| +3% | +$836K |
|
269
Evercore
EVR
$11.8B
| $34.1M | 0.07% |
101,049
-3,010
| -3% | -$943K |
|
270
Boston Scientific
BSX
$71.5B
| $34.1M | 0.07% |
348,841
+123,185
| +55% | +$12.8M |
|
271
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$40.9B
| $33.8M | 0.07% |
587,162
-18,495
| -3% | -$1.03M |
|
272
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $33.5M | 0.07% |
104,769
+7,294
| +7% | +$2.2M |
|
273
iShares 0-3 Month Treasury Bond ETF
SGOV
$100B
| $33.5M | 0.07% |
332,758
+18,596
| +6% | +$1.87M |
|
274
Vanguard Consumer Discretionary ETF
VCR
$6.33B
| $33.5M | 0.07% |
84,528
+4,414
| +6% | +$1.68M |
|
275
iShares MSCI EAFE Value ETF
EFV
$29.4B
| $33.1M | 0.06% |
488,514
+33,847
| +7% | +$2.23M |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Rockefeller Capital Management held 4,443 positions worth $51.1B, up 12% from $45.6B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Rockefeller Capital Management deployed $2.51B of net new capital in Q3 2025, opening 2,726 new positions and adding to 876 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 87 shares worth $65.6M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $52.3M trimmed.
- Rockefeller Capital Management's largest Q3 2025 buy was Berkshire Hathaway Class A: 87 shares worth $65.6M.
- Rockefeller Capital Management added most to Salesforce in Q3 2025, an estimated $1.21B increase.
- Rockefeller Capital Management's biggest Q3 2025 reduction was Advanced Micro Devices, cutting an estimated $52.3M.
- Rockefeller Capital Management fully exited Ansys in Q3 2025, selling an estimated $15M.
- Rockefeller Capital Management's ten largest holdings make up 25% of its $51.1B portfolio in Q3 2025.
- Rockefeller Capital Management opened 2,726 new positions and closed 17 in Q3 2025.
- Rockefeller Capital Management's portfolio value rose 12% quarter-over-quarter to $51.1B.
Based on Rockefeller Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.